A linear relationship between the ex-vivo sodium mediated expression of two sodium regulatory pathways as a surrogate marker of salt sensitivity of blood pressure in exfoliated human renal proximal tubule cells: The virtual renal biopsy

Clinica Chimica Acta

Volumn 421, Issue , 2013, Pages 236-242

  Gildea, John J ^a   Lahiff, Dylan T ^a   Van Sciver, Robert E ^a   Weiss, Ryan S ^a   Shah, Neema ^a   McGrath, Helen E ^a   Schoeffel, Cynthia D ^a   Jose, Pedro A ^b   Carey, Robert M ^a   Felder, Robin A ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

Cell based assay; Personalized medicine; Renal cells; Salt sensitivity; Sodium diet; Urinalysis

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; CALCIUM; DOPAMINE 1 RECEPTOR;

ARTICLE; BLOOD PRESSURE MEASUREMENT; CALCIUM CELL LEVEL; CARDIOVASCULAR DISEASE; CELL ASSAY; CELL ISOLATION; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; EX VIVO STUDY; HIGH SODIUM INTAKE; HUMAN; HUMAN CELL; KIDNEY BIOPSY; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALT LOADING; SALT SENSITIVITY OF BLOOD PRESSURE; SODIUM RESTRICTION; SODIUM TRANSPORT; URINALYSIS;

ANGIOTENSIN II; ARTERIAL PRESSURE; BIOLOGICAL MARKERS; CALCIUM; CELL SEPARATION; CELLS, CULTURED; EPITHELIAL CELLS; GENE EXPRESSION; HUMANS; KIDNEY TUBULES, PROXIMAL; RECEPTORS, DOPAMINE D1; SODIUM, DIETARY;

EID: 84876699147     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2013.02.021     Document Type: Article

References (76)

1. Alderman M.H., Cohen H.W. Dietary sodium intake and cardiovascular mortality: controversy resolved?. Curr Hypertens Rep 2012, 14:193-201.
2. Suematsu N., Ojaimi C., Recchia F.A., et al. Potential mechanisms of low-sodium diet-induced cardiac disease: superoxide-NO in the heart. Circ Res 2010, 106:593-600.
3. Stolarz-Skrzypek K., Kuznetsova T., Thijs L., et al. Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA 2011, 305:1777-1785.
4. O'Donnell M.J., Yusuf S., Mente A., et al. Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA 2011, 306:2229-2238.
5. Dorresteijn J.A., van der Graaf Y., Spiering W., et al. Relation between blood pressure and vascular events and mortality in patients with manifest vascular disease: J-curve revisited. Hypertension 2012, 59:14-21.
6. Felder R.A., White M.J., Williams S.M., Jose P.A. Diagnostic tools for hypertension and salt sensitivity testing. Curr Opin Nephrol Hypertens 2013, 22:65-76.
7. Rahmoune H., Thompson P.W., Ward J.M., Smith C.D., Hong G., Brown J. Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes. Diabetes 2005, 54:3427-3434.
8. Crowley S.D., Gurley S.B., Herrera M.J., et al. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci U S A 2006, 103:17985-17990.
9. Asico L., Zhang X., Jiang J., et al. Lack of renal dopamine D5 receptors promotes hypertension. J Am Soc Nephrol 2011, 22:82-89.
10. Rodriguez-Iturbe B., Franco M., Johnson R.J. Impaired pressure natriuresis is associated with interstitial inflammation in salt-sensitive hypertension. Curr Opin Nephrol Hypertens 2013, 22:37-44.
11. Aviv A., Hollenberg N.K., Weder A. Urinary potassium excretion and sodium sensitivity in blacks. Hypertension 2004, 43:707-713.
12. Doris P.A. Renal proximal tubule sodium transport and genetic mechanisms of essential hypertension. J Hypertens 2000, 18:509-519.
13. Weinberger M.H., Fineberg N.S., Fineberg S.E., Weinberger M. Salt sensitivity, pulse pressure, and death in normal and hypertensive humans. Hypertension 2001, 37:429-432.
14. Kato N., Kanda T., Sagara M., et al. Proposition of a feasible protocol to evaluate salt sensitivity in a population-based setting. Hypertens Res 2002, 25:801-809.
15. Nichols J., Elijovich F., Laffer C.L. Lack of validation of a same-day outpatient protocol for determination of salt sensitivity of blood pressure. Hypertension 2012, 59:390-394.
16. de la Sierra A., Giner V., Bragulat E., Coca A. Lack of correlation between two methods for the assessment of salt sensitivity in essential hypertension. J Hum Hypertens 2002, 16:255-260.
17. Kawasaki T., Delea C.S., Bartter F.C., Smith H. The effect of high-sodium and low-sodium intakes on blood pressure and other related variables in human subjects with idiopathic hypertension. Am J Med 1978, 64:193-198.
18. Siragy H.M., Felder R.A., Howell N.E., Chevalier R.L., Peach M.J., Carey R.M. Intrarenal dopamine acts at the dopamine-1 receptor to control renal function. J Hypertens 1988, 6:S479-S481. [Suppl.].
19. Jose P.A., Soares-da-Silva P., Eisner G.M., Felder R.A. Dopamine and G protein-coupled receptor kinase 4 in the kidney: role in blood pressure regulation. Biochim Biophys Acta 1802, 2010:1259-1267.
20. Felder R.A., Sanada H., Xu J., et al. G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc Natl Acad Sci U S A 2002, 99:3872-3877.
21. + regulates dopamine and angiotensin II receptors availability at the plasma membrane and their cellular responses in renal epithelia. J Biol Chem 2003, 278:28719-28726.
22. Sanada H., Jose P.A., Hazen-Martin D., et al. Dopamine-1 receptor coupling defect in renal proximal tubule cells in hypertension. Hypertension 1999, 33:1036-1042.
23. Khan F., Spicarová Z., Zelenin S., Holtbäck U., Scott L., Aperia A. Negative reciprocity between angiotensin II type 1 and dopamine D1 receptors in rat renal proximal tubule cells. Am J Physiol Renal Physiol 2008, 295:F1110-F1116.
24. Zeng C., Luo Y., Asico L.D., et al. Perturbation of D1 dopamine and AT1 receptor interaction in spontaneously hypertensive rats. Hypertension 2003, 42:787-792.
25. Chugh G., Lokhandwala M.F., Asghar M. Oxidative stress alters renal D1 and AT1 receptor functions and increases blood pressure in old rats. Am J Physiol Renal Physiol 2011, 300:F133-F138.
26. Williams S.M., Addy J.H., Phillips J.A., et al. Combinations of variations in multiple genes are associated with hypertension. Hypertension 2000, 36:2-6.
27. Sanada H., Yatabe J., Midorikawa S., et al. Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension. Clin Chem 2006, 52:352-360.
28. Gildea J., Yatabe J., Sasaki M., Wang X., Jose P., Felder R. Up-regulation of the angiotensin type II receptor by dopamine-1 receptor stimulation in normotensive but not hypertensive human renal proximal tubule cells block angiotensin II dependent down-regulation of caveolin 1. Hypertension 2005; Abstract for 59th Annual Fall Conference and Scientific Sessions of Council for High Blood Pressure Research, Washington, DC September 2005.
29. Racusen L.C., Fivush B.A., Andersson H., Gahl W.A. Culture of renal tubular cells from the urine of patients with nephropathic cystinosis. J Am Soc Nephrol 1991, 1:1028-1033.
30. Racusen L.C., Wilson P.D., Hartz P.A., Fivush B.A., Burrow C.R. Renal proximal tubular epithelium from patients with nephropathic cystinosis: immortalized cell lines as in vitro model systems. Kidney Int 1995, 48:536-543.
31. Inoue C.N., Kondo Y., Ohnuma S., Morimoto T., Nishio T., Iinuma K. Use of cultured tubular cells isolated from human urine for investigation of renal transporter. [Erratum appears in Clin Nephrol 2000 Jun;53(6):492]. Clin Nephrol 2000, 53:90-98.
32. Laube G.F., Haq M.R., van't Hoff W.G. Exfoliated human proximal tubular cells: a model of cystinosis and Fanconi syndrome. Pediatr Nephrol 2005, 20:136-140.
33. Carey R.M., Schoeffel C.D., Gildea J.J., et al. Salt sensitivity of blood pressure is associated with polymorphisms in the sodium-bicarbonate cotransporter. Hypertension 2012, 60:1359-1366.
34. Levey A.S., Eckardt K.U., Tsukamoto Y., et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005, 67:2089-2100.
35. Prescott L.F. The normal urinary excretion rates of renal tubular cells, leucocytes and red blood cells. Clin Sci 1966, 31:425-435.
36. Zhou T., Benda C., Dunzinger S., et al. Generation of human induced pluripotent stem cells from urine samples. Nat Protoc 2012, 7:2080-2089.
37. Amsellem S., Gburek J., Hamard G., et al. Cubilin is essential for albumin reabsorption in the renal proximal tubule. J Am Soc Nephrol 2010, 21:1859-1867.
38. Helbert M.J., Dauwe S.E., Van der Biest I., Nouwen E.J., De Broe M.E. Immunodissection of the human proximal nephron: flow sorting of S1S2S3, S1S2 and S3 proximal tubular cells. Kidney Int 1997, 52:414-428.
39. Baer P.C., Nockher W.A., Haase W., Scherberich J.E. Isolation of proximal and distal tubule cells from human kidney by immunomagnetic separation. Technical note. Kidney Int 1997, 52:1321-1331.
40. Gildea J.J., Shah I., Weiss R., et al. HK-2 human renal proximal tubule cells as a model for G protein-coupled receptor kinase type 4-mediated dopamine 1 receptor uncoupling. Hypertension 2010, 56:505-511.
41. Grupp C., Hemprich U., John H., et al. Lectin staining for urine cytologic monitoring after kidney transplantation. Nephrol Dial Transplant 2002, 17:1491-1496.
42. Gildea J.J., Israel J.A., Johnson A.K., Zhang J., Jose P.A., Felder R.A. Caveolin-1 and dopamine-mediated internalization of NaKATPase in human renal proximal tubule cells. Hypertension 2009, 54:1070-1076.
43. Gildea J.J., McGrath H.E., Van Sciver R.E., Wang D.B., Felder R.A. Isolation, growth, and characterization of human renal epithelial cells using traditional and 3D methods. Methods Mol Biol 2013, 945:329-345.
44. Takahashi A., Camacho P., Lechleiter J.D., Herman B. Measurement of intracellular calcium. Physiol Rev 1999, 79:1089-1125.
45. Seikaly M.G., Arant B.S., Seney F.D. Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat. J Clin Invest 1990, 86:1352-1357.
46. Braam B., Mitchell K.D., Fox J., Navar L.G. Proximal tubular secretion of angiotensin II in rats. Am J Physiol 1993, 264:F891-F898.
47. Gildea J.J., Wang X., Shah N., et al. Dopamine and Angiotensin type 2 receptors cooperatively inhibit sodium transport in human renal proximal tubule cells. Hypertension 2012, 60:396-403.
48. Strazzullo P., D'Elia L., Kandala N.B., Cappuccio F.P. Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies. BMJ 2009, 339:b4567.
49. He F.J., MacGregor G.A. Reducing population salt intake worldwide: from evidence to implementation. Prog Cardiovasc Dis 2010, 52:363-382.
50. Weinberger M.H. Salt sensitivity of blood pressure in humans. Hypertension 1996, 27:481-490.
51. Overlack A., Ruppert M., Kolloch R., et al. Divergent hemodynamic and hormonal responses to varying salt intake in normotensive subjects. Hypertension 1993, 22:331-338.
52. Yatabe M.S., Yatabe J., Yoneda M., et al. Salt sensitivity is associated with insulin resistance, sympathetic overactivity, and decreased suppression of circulating renin activity in lean patients with essential hypertension. Am J Clin Nutr 2010, 92:77-82.
53. Racusen L.C., Fivush B.A., Li Y.L., Slatnik I., Solez K. Dissociation of tubular cell detachment and tubular cell death in clinical and experimental "acute tubular necrosis". Lab Investig 1991, 64:546-556.
54. Racusen L.C., Solez K. Ideas in pathology. Exfoliation of renal tubular cells. Mod Pathol 1991, 4:368-370.
55. Racusen L.C., Monteil C., Sgrignoli A., et al. Cell lines with extended in vitro growth potential from human renal proximal tubule: characterization, response to inducers, and comparison with established cell lines. J Lab Clin Med 1997, 129:318-329.
56. Banday A.A., Lokhandwala M.F. Dopamine receptors and hypertension. Curr Hypertens Rep 2008, 10:268-275.
57. O'Connell D.P., Ragsdale N.V., Boyd D.G., Felder R.A., Carey R.M. Differential human renal tubular responses to dopamine type 1 receptor stimulation are determined by blood pressure status. Hypertension 1997, 29:115-122.
58. Hiranyachattada S., Harris P.J. Regulation of renal proximal fluid uptake by luminal and peritubular angiotensin II. J Renin Angiotensin Aldosterone Syst 2004, 5:89-92.
59. DiBona G.F. Sympathetic nervous system and the kidney in hypertension. Curr Opin Nephrol Hypertens 2002, 11:197-200.
60. 2+ exchanger type-1 in vascular smooth muscle. Nat Med 2004, 10:1193-1199.
61. Ducher M., Bertram D., Pozet N., Laville M., Fauvel J.P. Stress-induced renal alterations in normotensives offspring of hypertensives and in hypertensives. Am J Hypertens 2002, 15:346-350.
62. Davy K.P., Hall J.E. Obesity and hypertension: two epidemics or one?. Am J Physiol Regul Integr Comp Physiol 2004, 286:R803-R813.
63. Lebel M., Grose J.H., Blais R. Abnormal relation of extracellular fluid volume and exchangeable sodium with systemic arterial pressure in early borderline essential hypertension. Am J Cardiol 1984, 54:1267-1271.
64. Beretta-Piccoli C., Weidmann P. Circulatory volume in essential hypertension. Relationships with age, blood pressure, exchangeable sodium, renin, aldosterone and catecholamines. Miner Electrolyte Metab 1984, 10:292-300.
65. Titze J., Machnik A. Sodium sensing in the interstitium and relationship to hypertension. Curr Opin Nephrol Hypertens 2010, 19:385-392.
66. Ortiz P.A., Garvin J.L. Intrarenal transport and vasoactive substances in hypertension. Hypertension 2001, 38:621-624.
67. Strazzullo P., Galletti F., Barba G. Altered renal handling of sodium in human hypertension: short review of the evidence. Hypertension 2003, 41:1000-1005.
68. Chiolero A., Maillard M., Nussberger J., Brunner H.R., Burnier M. Proximal sodium reabsorption: an independent determinant of blood pressure response to salt. Hypertension 2000, 36:631-637.
69. Lifton R.P., Wilson F.H., Choate K.A., Geller D.S. Salt and blood pressure: new insight from human genetic studies. Cold Spring Harb Symp Quant Biol 2002, 67:445-450.
70. DiBona G.F., Esler M. Translational medicine: the antihypertensive effect of renal denervation. Am J Physiol Regul Integr Comp Physiol 2010, 298:R245-R253.
71. Navar L.G., Prieto M.C., Satou R., Kobori H. Intrarenal angiotensin II and its contribution to the genesis of chronic hypertension. Curr Opin Pharmacol 2011, 11:180-186.
72. Grisk O., Heukaufer M., Steinbach A., Gruska S., Rettig R. Analysis of arterial pressure regulating systems in renal post-transplantation hypertension. J Hypertens 2004, 22:199-207.
73. Wang Z.Q., Felder R.A., Carey R.M. Selective inhibition of the renal dopamine subtype D1A receptor induces antinatriuresis in conscious rats. Hypertension 1999, 33:504-510.
74. Siragy H.M., Felder R.A., Howell N.L., Chevalier R.L., Peach M.J., Carey R.M. Evidence that intrarenal dopamine acts as a paracrine substance at the renal tubule. Am J Physiol 1989, 257:F469-F477.
75. Hansell P., Fasching A. The effect of dopamine receptor blockade on natriuresis is dependent on the degree of hypervolemia. Kidney Int 1991, 39:253-258.
76. Zhang M.Z., Yao B., Wang S., et al. Intrarenal dopamine deficiency leads to hypertension and decreased longevity in mice. J Clin Invest 2011, 121:2845-2854.